PT  - JOURNAL ARTICLE
AU  - Michael A. Mooney
AU  - Robert J.M. Hermosillo
AU  - Eric Feczko
AU  - Oscar Miranda-Dominguez
AU  - Lucille A. Moore
AU  - Anders Perrone
AU  - Nora Byington
AU  - Gracie Grimsrud
AU  - Amanda Rueter
AU  - Elizabeth Nousen
AU  - Dylan Antovich
AU  - Sarah W. Feldstein Ewing
AU  - Bonnie J. Nagel
AU  - Joel T. Nigg
AU  - Damien A. Fair
TI  - Cumulative Effects of Resting-state Connectivity Across All Brain Networks Significantly Correlate with ADHD Symptoms
AID  - 10.1101/2021.11.16.21266121
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.11.16.21266121
4099  - http://medrxiv.org/content/early/2021/11/20/2021.11.16.21266121.short
4100  - http://medrxiv.org/content/early/2021/11/20/2021.11.16.21266121.full
AB  - Background The clinical utility of MRI neuroimaging studies of psychopathology has been limited by a constellation of factors—small sample sizes, small effect sizes, and heterogeneity of methods and samples across studies—that hinder generalizability and specific replication. An analogy is early genomics studies of complex traits, wherein a move to large, multi-site samples and a focus on cumulative effects (polygenic scores) led to reproducible and clinically applicable effects from genome-wide association studies. A similar logic in MRI may provide a way to improve reproducibility, precision, and clinical utility for brain-wide MRI association studies.Methods Polyneuro scores (PNS) represent the cumulative effect of brain-wide measures—in the present case, resting-state functional connectivity (rs-fcMRI) associated with ADHD symptoms. These scores were constructed and validated using baseline data from the Adolescent Brain Cognitive Development (ABCD, N=5666) study, with a reproducible matched subset as the discovery cohort (N=2801). Association between the PNS and ADHD symptoms was further tested in an independent case-control cohort, the Oregon-ADHD-1000 (N=533).Results The ADHD PNS was significantly associated with ADHD symptoms in both the ABCD and Oregon cohorts after accounting for relevant covariates (p-values < 0.001). While the strongest effects contributing to the PNS were concentrated among connections involving the default mode and cingulo-opercular networks, the most predictive PNS involved connectivity across all brain networks. These findings were robust to stringent motion thresholds. In the longitudinal Oregon-ADHD-1000, non-ADHD comparison youth had significantly lower ADHD PNS (β=-0.309, p=0.00142) than children with persistent ADHD (met diagnostic criteria at two or more time points from age 7 to 19). The ADHD PNS, however, did not reliably mediate polygenic risk for ADHD. Instead, the PNS and an ADHD polygenic score were independently associated with ADHD symptoms.Conclusions A polyneuro risk score representing cumulative ADHD-associated resting-state connectivity was robustly associated with ADHD symptoms in two independent cohorts using distinct sampling designs, yet was independent of polygenic liability for ADHD, suggesting the need to examine environmental influences. The polyneuro score approach holds promise for improving the reproducibility of neuroimaging studies, identifying their clinical utility, and unraveling the complex relationships between brain connectivity and the etiology of behavioral disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the National Institute of Mental Health of the National Institutes of Health under award numbers: R01MH115357 (Fair and Nigg), R37MH059105 (Nigg), U01DA041148 (Fair, Nagel, Feldstein Ewing), and U24DA041123 (Fair).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves publicly available data, which can be obtained from the NIMH Data Archive (NDA Collection 3165 and NDA Collection 2857).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the present study is publicly available on the NIMH Data Archive. http://dx.doi.org/10.15154/1504041 https://collection3165.readthedocs.io/en/stable/ https://nda.nih.gov/edit_collection.html?id=3165 https://nda.nih.gov/edit_collection.html?id=2857